Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceuticals Industries Ltd SUNPHARMA | 1,878 | 163.45 | 4,50,595.11 | 863.29 | 0.72 | 5,123.67 | 98.33 |
Divis Laboratories Ltd DIVISLAB | 6,143.45 | 88.78 | 1,63,089.29 | 518 | 0.49 | 2,302 | 513.62 |
Cipla Ltd CIPLA | 1,537.55 | 29.33 | 1,24,174.7 | 1,178.16 | 0.85 | 3,969.86 | 360.73 |
Mankind Pharma Ltd MANKIND | 2,899.55 | 59.69 | 1,19,625.84 | 634.43 | 0 | 2,529.74 | 334.18 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,446.25 | 71.29 | 1,16,631.52 | 460 | 0.81 | 2,376 | 222.38 |
No Record Found
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Capital Services Ltd. All Rights Reserved
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
